Published in EMBO J on June 01, 1991
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J (2001) 5.23
Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest (1998) 2.68
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J Clin Invest (1999) 1.56
Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin. Nucleic Acids Res (1991) 1.52
Association of cystic fibrosis transmembrane conductance regulator gene variants with acute lung injury in African American children with pneumonia*. Crit Care Med (2012) 1.46
Chronic pancreatitis and cystic fibrosis. Gut (2003) 0.98
Accurate typing of short tandem repeats from genome-wide sequencing data and its applications. Genome Res (2015) 0.96
Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping. Am J Hum Genet (2002) 0.88
In vivo readout of CFTR function: ratiometric measurement of CFTR-dependent secretion by individual, identifiable human sweat glands. PLoS One (2013) 0.87
The CFTR polymorphisms poly-T, TG-repeats and M470V in Chinese males with congenital bilateral absence of the vas deferens. Asian J Androl (2012) 0.84
Long-range (17.7 kb) allele-specific polymerase chain reaction method for direct haplotyping of R117H and IVS-8 mutations of the cystic fibrosis transmembrane regulator gene. J Mol Diagn (2004) 0.84
CFTR expression from a BAC carrying the complete human gene and associated regulatory elements. J Cell Mol Med (2008) 0.83
The cystic fibrosis gene: a molecular genetic perspective. Cold Spring Harb Perspect Med (2013) 0.81
Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7. Genome Res (2000) 0.80
The two small introns of the Drosophila affinidisjuncta Adh gene are required for normal transcription. Nucleic Acids Res (1996) 0.78
Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770. Am J Physiol Lung Cell Mol Physiol (2016) 0.77
CFTR polymorphisms of healthy individuals in two Chinese cities--Changchun and Nanjing. Nagoya J Med Sci (2012) 0.75
The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements. PLoS One (2017) 0.75
Cystic fibrosis transmembrane conductance regulator (CFTR) gene transcripts. EMBO J (1992) 0.75
CFTR Modulator Therapies in Pediatric Cystic Fibrosis: Focus on Ivacaftor. Expert Opin Orphan Drugs (2016) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science (1989) 40.22
Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J (1982) 38.14
Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61
Identification of the cystic fibrosis gene: chromosome walking and jumping. Science (1989) 21.46
The P-loop--a common motif in ATP- and GTP-binding proteins. Trends Biochem Sci (1990) 14.55
Splicing of messenger RNA precursors. Annu Rev Biochem (1986) 14.41
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell (1990) 9.21
Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res (1989) 9.04
Spliceosomal snRNAs. Annu Rev Genet (1988) 8.09
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell (1987) 7.25
Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature (1990) 6.41
A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature (1990) 5.42
The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature (1990) 4.26
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70
Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science (1986) 3.40
Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell (1990) 3.29
Extensive editing of the cytochrome c oxidase III transcript in Trypanosoma brucei. Cell (1988) 3.26
Regulation of chloride channels by protein kinase C in normal and cystic fibrosis airway epithelia. Science (1989) 2.46
A U-rich tract enhances usage of an alternative 3' splice site in yeast. Cell (1991) 2.45
Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. N Engl J Med (1990) 2.37
A frame-shift mutation in the cystic fibrosis gene. Nature (1990) 2.23
Cl- channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase. Science (1989) 2.12
Cystic fibrosis. Complementary endeavours. Nature (1990) 1.06
A novel beta thalassemia gene with a single base mutation in the conserved polypyrimidine sequence at the 3' end of IVS 2. Nucleic Acids Res (1988) 0.91
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (1991) 11.44
In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell (1992) 5.85
Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain. Proc Natl Acad Sci U S A (1996) 5.84
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol (1996) 5.71
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (1987) 5.45
Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature (1992) 5.45
Chromogenic identification of genetic regulatory signals in Bacillus subtilis based on expression of a cloned Pseudomonas gene. Proc Natl Acad Sci U S A (1983) 5.33
The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr (1998) 5.08
Herbal medicines and perioperative care. JAMA (2001) 5.05
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol (1996) 4.97
New versatile cloning and sequencing vectors based on bacteriophage M13. Gene (1983) 4.55
The skipping of constitutive exons in vivo induced by nonsense mutations. Science (1993) 4.41
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med (2001) 3.72
CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell (1995) 3.46
Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood (2000) 3.36
Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (1984) 3.32
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet (1993) 3.22
Activation of adenylate cyclase by choleragen. Annu Rev Biochem (1979) 3.16
GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity (2001) 3.13
Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase. Proc Natl Acad Sci U S A (1976) 2.98
Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci U S A (1984) 2.85
Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J Biol Chem (1977) 2.76
cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett (1991) 2.70
Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature (1992) 2.67
Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest (1999) 2.65
Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. J Biol Chem (1985) 2.64
Linker tailing: unphosphorylated linker oligonucleotides for joining DNA termini. DNA (1984) 2.56
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucleic Acids Res (1983) 2.56
Species and type phages of lactococcal bacteriophages. Intervirology (1991) 2.55
The biotin-dependent enzymes. Adv Enzymol Relat Areas Mol Biol (1971) 2.45
In vivo model of adeno-associated virus vector persistence and rescue. J Virol (1996) 2.41
Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res (2000) 2.37
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet (1993) 2.31
Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci U S A (1984) 2.23
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A (2000) 2.21
Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. Proc Natl Acad Sci U S A (1976) 2.14
Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors. Biotechniques (1992) 2.09
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc Natl Acad Sci U S A (1998) 2.08
Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol (2000) 2.07
Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene. J Clin Invest (1984) 2.07
Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen. J Clin Invest (1978) 2.07
Cell-free synthesis of enterotoxin of E. coli from a cloned gene. Nature (1980) 2.02
Regulation of enzyme synthesis in the arginine deiminase pathway of Pseudomonas aeruginosa. J Bacteriol (1980) 2.01
Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells. J Biol Chem (1991) 1.99
Acetyl coenzyme A carboxylase system of Escherichia coli. Purification and properties of the biotin carboxylase, carboxyltransferase, and carboxyl carrier protein components. J Biol Chem (1974) 1.99
Catabolism of L-arginine by Pseudomonas aeruginosa. J Gen Microbiol (1980) 1.98
Mortality variation across Australia: descriptive data for states and territories, and statistical divisions. Aust N Z J Public Health (2000) 1.98
Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr (1998) 1.97
Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun (1999) 1.95
Transposon insertion mutagenesis of Pseudomonas aeruginosa with a Tn5 derivative: application to physical mapping of the arc gene cluster. Gene (1985) 1.94
Acetyl coenzyme A carboxylase. Curr Top Cell Regul (1974) 1.94
Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. Hum Pathol (2000) 1.93
Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands. Eur Respir J (1993) 1.90
Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet (1997) 1.84
Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther (1996) 1.84
Adaptation of the nisin-controlled expression system in Lactobacillus plantarum: a tool to study in vivo biological effects. Appl Environ Microbiol (2000) 1.82
Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem (2000) 1.82
Identification of antigens and antibodies specific for Pneumocystis carinii. J Immunol (1988) 1.81
Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell (1992) 1.81
Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem (1998) 1.81
Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors. J Biol Chem (1999) 1.78
Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucleic Acids Res (1992) 1.75
Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes. Proc Natl Acad Sci U S A (1994) 1.74
Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J Biol Chem (1983) 1.74
Lymphangioleiomyomatosis: what do we know and what are we looking for? Eur Respir Rev (2011) 1.73
Molecular characterization of a 23-kilodalton major antigen secreted by Toxoplasma gondii. Proc Natl Acad Sci U S A (1989) 1.73
A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest (1999) 1.73
A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol (1991) 1.72
Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm (1979) 1.72
Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Hum Mutat (1992) 1.71
The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. J Biol Chem (1991) 1.70
Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J Clin Invest (1992) 1.68
Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. Radiology (2001) 1.67
ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J Biol Chem (1984) 1.67
Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain. J Biol Chem (1988) 1.67
Clinical and genetic studies of an autosomal dominant cone-rod dystrophy with features of Stargardt disease. Ophthalmic Genet (1999) 1.66
High-level production of biologically active human alpha 1-antitrypsin in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.65
beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J Biol Chem (2001) 1.63
Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex. Proc Natl Acad Sci U S A (2000) 1.62
Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A (1992) 1.62
Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor. Proc Natl Acad Sci U S A (1997) 1.62
Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA (2000) 1.62
Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi. J Biol Chem (1993) 1.61
Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy. J Virol (1996) 1.61
Binding sites of the 9- and 14-kilodalton heterodimeric protein subunit of the signal recognition particle (SRP) are contained exclusively in the Alu domain of SRP RNA and contain a sequence motif that is conserved in evolution. Mol Cell Biol (1991) 1.61
Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J Biol Chem (1989) 1.61
Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology (1998) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60